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Abstract
Cyanobactins are cyclic peptides assembled through the cleavage and modification of short precursor proteins. An inactive
cyanobactin gene cluster has been described from the genome Microcystis aeruginosa NIES843. Here we report the
discovery of active counterparts in strains of the genus Microcystis guided by this silent cyanobactin gene cluster. The end
products of the gene clusters were structurally diverse cyclic peptides, which we named piricyclamides. Some of the
piricyclamides consisted solely of proteinogenic amino acids while others contained disulfide bridges and some were
prenylated or geranylated. The piricyclamide gene clusters encoded between 1 and 4 precursor genes. They encoded highly
diverse core peptides ranging in length from 7–17 amino acids with just a single conserved amino acid. Heterologous
expression of the pir gene cluster from Microcystis aeruginosa PCC7005 in Escherichia coli confirmed that this gene cluster is
responsible for the biosynthesis of piricyclamides. Chemical analysis demonstrated that Microcystis strains could produce an
array of piricyclamides some of which are geranylated or prenylated. The genetic diversity of piricyclamides in a bloom
sample was explored and 19 different piricyclamide precursor genes were found. This study provides evidence for
a stunning array of piricyclamides in Microcystis, a worldwide occurring bloom forming cyanobacteria.
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Introduction
Cyanobactins are small cyclic peptides with interesting phar-
maceutical properties including antimicrobial activity against
human pathogens [1–4]. Cyanobactins are true ribosomal gene
products and made through the enzymatic modification of short
precursor peptides [4–5]. Cyanobactin biosynthetic gene clusters
encode two proteases responsible for the cleavage and cyclization
of one or more precursor peptides [4–7]. The heterocyclization of
threonines, serines and cysteines is a common post-translational
modification in cyanobactin biosynthesis [8–9]. The heterocycli-
zation of threonines, serines and cysteines to form oxazoles and
thiazoles as well as the oxidation to oxazolines and thiazolines has
been described in detail [8–9]. Disulfide bridge formation and
prenylation or geranylation or specific amino acids have also been
reported [4,7,10,11,12]. Prenylation occurs as a last step process
after the heterocyclization, cleavage and macrocyclization of the
precursor peptide to the final cyclic peptide [11].
The cyanobactin biosynthetic pathway is known from a range of
cyanobacteria e.g. Prochloron, Arthrospira platensis, Planktothrix agardhii,
Oscillatoria, Nostoc and Anabaena [7,10–15]. Microcystis strains
produce microcyclamides, which are hexapeptides with varying
amino acid content and which carry heterocyclized amino acids at
every second position [3,15,16–18]. Microcyclamides have been
shown to have cytotoxic activities against murine leukemia cells,
toxic effects on crustacean Thamnocephalus platyurus and Plasmodium
falciparum [3,16]. A cyanobactin gene cluster with an unknown
end-product was reported from the complete genome of Microcystis
aeruginosa NIES843 [7,19]. However, this cluster is disrupted by
large insertions and rearrangements and appears to be non-
functional [7].
Here we report a natural product discovery driven by
bioinformatic analysis of an inactive gene cluster. This new family
of prenylated and geranylated cyanobactins, which we named
piricyclamides, is common in strains of the genus Microcystis.
Results
Inactive Gene Cluster used to Find a Functional
Counterpart
Bioinformatic analysis demonstrated that the cyanobactin gene
cluster from Microcystis aeruginosa NIES843 was inactivated by two
insertion elements (Figure 1). We screened 74 Microcystis strains
with PCR and LC-MS to discover active producers of similar
cyanobactins. These strains were screened simultaneously by LC-
MS based mainly on the fragmentation pattern typical for
cyanobactins containing isoprenoid units linked to heteroatoms.
The presence of isoprenoid unit (68 Da) is clearly seen in MS and
MS2 spectra as a neutral loss of 68 and 136 (Figure S1A–C).
Potential cyanobactin candidates were found in 10 out of the 74
strains. Simultaneously the piricyclamide precursor genes were
amplified by PCR using primers designed to anneal specifically in
the N- and C-terminal of all three precursors encoded in the
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e43002
cyanobactin gene cluster in Microcystis aeruginosa NIES843. Pre-
cursor genes were amplified from 28 out of the 74 strains. Six of
these 28 strains produced prenylated cyanobactin candidates
detected by LC-MS. These 6 strains for which both precursor
genes and candidate cyanobactins could be identified were
predicted to contain active piricyclamide gene clusters and were
studied further. Clone libraries of the amplified precursors from
the 6 Microcystis strains, Izancya36, Izancya41, Izancya42,
SYKE764, SYKE864 and PCC7005, were constructed and ten
clones were sequenced from each library. Each of the 6 strains had
between 2 and 4 cyanobactin precursor genes. The end products
of the new piricyclamide gene clusters were predicted from the
precursor genes (Table 1).
Discovery of Piricyclamides
The mass of the putative cyanobactins detected by LC-MS were
used together with the precursor peptide sequences to predict
cleavage sites. These predictions were confirmed by derivatization
and labeling experiments. Microcystis strains were cultivated on 15N
stable isotope containing medium to verify the piricyclamide
structures. The cell extracts were analysed by LC-MS. Increased
molecular mass values (MH+) of the 15N-labelled piricyclamides
matched with the values calculated from the amino acid sequences
and confirmed the number of nitrogen atoms and the piricycla-
mide structures (Table S4). Four piricyclamides, WILLADGTRP-
KNAP, FAIFLLLP, SQWGWRGLSDP and GTHLYTITP,
contained only proteinogenic amino acids and no further evidence
of post-translational modifications other than macrocyclization
was found by LC-MS (Figure S1E, F, K and L, Table 1, Table S4,
Table S5).
Some of the predicted piricyclamides, MSGVDYYNP,
NEFMQTGSYSGP and TLGCMNGTERCLGLP, contained
a methionine residue. These piricyclamides had 16 Da higher
masses and which eluted slightly earlier in reversed phase
chromatography because they contained methionine sulphoxide,
a well-known methionine oxidation product that probably had
formed during sample preparation. Methionine sulphoxide
Figure 1. Schematic drawing of the pir gene clusters, precursor sequences and structures of piricyclamides. These are found in the
genome of M. aeruginosa PCC7005 (A) and NIES843 (B). The genes in green are the precursor genes, proteases are blue, prenyltransterase is grey and
typical genes for cyanobactin with no predicted function are orange. Piricyclamides produced from PirE1-PirE4 precursors by the M. aeruginosa
PCC7005 are shown. Above the precursors the site is shown the annealing site of the primers used in the precursor gene amplification. Interruptions
of the pir genes in M. aeruginosa NIES843 are indicated with red triangles and deletion with a red circle at 508 position of pirG. The length of the pir
gene cluster is from pirE2 to pirG 9.4 kb. The entire length of the gene cluster area in M. aeruginosa NIES843 including the insertions is from the
beginning of pirE1 to pirG is 19.6 kb. The amino acid sequences of the precursors are aligned below the gene cluster.
doi:10.1371/journal.pone.0043002.g001
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specific elimination of CH3SOH [20] was detected in the
product ion spectra of these piricyclamide variants.
Some of the core regions of the precursor peptides displayed
a double cysteine pattern suggesting that they encoded piricycla-
mides which contain disulfide bridges. The presence of sulphur in
piricyclamide TLGCMNGTERCLGLP was shown by cultivation
of Microcystis Izancya 41 in medium containing stable isotope 34S
instead of standard isotope 32S. 34S-labelling increased the mass of
piricyclamide TLGCMNGTERCLGLP by 4 Da which, demon-
strated the presence of two sulphur atoms in the cyanobactin.
Disulfide bridges were subsequently identified in two piricycla-
mides TFCDLATKQCYP and TLGCMNGTERCLGLP
(Table 1). Disulfide bridge structure was verified by reduction
and cysteine specific carboxyamidomethylation of the peptide
[21]. Derivatization shifted the mass of the protonated piricycla-
mide ion by 116 Da (from m/z 1544 to m/z 1660 [MH]+)
demonstrating the existence of a single disulfide bridge. Further
proof was obtained from the product ion spectra of the derivatized
piricyclamide TLGCMNGTERCLGLP which showed loss of 91
Da fragment H2NC(=O)CH2SH specific for carboxyamido-
methylated cysteine (Figure S1H).
Chemical Diversity of Piricyclamides
Piricyclamides MSGVDYYNP and NEFMQTGSYSGP in M.
aeruginosa PCC7005 (Table 1) were detected only 136 Da larger
variants than predicted from the precursor peptide sequence.
Loss of 136 Da fragment dominated the product ion spectra of
both piricyclamides and the loss of the fragment was seen
already in ion source (Figure S1B, C). 15N-labelling experiment
showed that the 136 Da additional structural unit did not
contain nitrogen (Figure S1 I, J). These results strongly indicate
that the piricyclamides MSGVDYYNP and NEFMQTGSYSGP
contain a heteroatom bound geranyl group. The ILGEGEGW-
NYNP piricyclamide had otherwise identical properties as the
geranylated piricyclamides but was detected only 68 Da larger
variant than predictable from the sequence (Figure S1A, G). In
this case the piricyclamide contained a heteroatom bound
prenyl group.
The GTHLYTITP piricyclamide was detected in an unmodified
form as predicted from the precursor sequence of the SYKE864
strain together with two larger peptides (84 Da and 84+68 Da) one
of which another contained a prenyl unit bound to a heteroatom
(Table S4, Figure S2A–C). 15N-labelling revealed equal nitrogen
content of these three peptides, which motivated the comparison of
the product ion spectra. Assignment of ions showed that several tri-
and tetrapeptide ions, which did not contain tyrosine (m/z 334,
375, 393, 488), were present in GTHLYTITP, prenylated and
nonprenylated peptide 1068 spectra. In contrast tyrosine contain-
ing tri- and tetrapeptide ions (m/z 360 and 497) were present in
GTHLYTITP spectrum were missing or had low intensity in Pr-
peptide 1068 and peptide 1068 spectra. 84 Da larger ions (m/z 444
and 581) were present in Pr-peptide 1068 and peptide 1068 spectra
(Figure S3). The higher mass fragment ions behaved identically
(Figure S2). These results suggest that Pr-peptide 1068 and peptide
1068 have otherwise same sequence than piricyclamide GTHLY-
TITP but instead of tyrosine there is an 84 Da larger amino acid or
tyrosine derivative. To further elucidate the structure of the
possible tyrosine derivative, peptide 1068 was analysed with
MALDI-TOF, which gave m/z 1068.546 for the protonated ion.
Theoretical mass for protonated piricyclamide GTHLYTITP is m/
z 984.5149 so the mass for the possible additional group in tyrosine
was 84.0311 Da. Two rational carbon, hydrogen and oxygen (15N
labelling showed lack of nitrogen) containing chemical formulas
within mass deviation of 50 mDa fitted to the mass and those were
C4H4O2 (D +14.4 mDa) and C5H8O (D 222.0 mDa). Latter
formula could represent a hydroxyprenyl group described as
a structural group in xanthone from a rain forest plant
psorospermum cf. molluscum [22].
Inactive Piricyclamide Gene Clusters
Bioinformatic analysis suggested that the cyanobactin gene
cluster from NIES843 is inactive (Figure 1). LC-MS analysis also
Table 1. The piricyclamide core sequences in the studied strains of Microcystis.
Piricyclamide core sequence Microcystis strain
PCC 7005 Izancya 36 Izancya 41 Izancya 42 SYKE 864 SYKE 764 NIES 843
NEFMQTGSYSGP Z, G
TFCDLATKQCYP Z, SS X* X
WILLADGTRPKNAP Z
MSGVDYYNP Z, G
TLGCMNGTERCLGLP Z, SS Z, SS
DWGTFCVQEDGEGNCKEWYEVP X X
DWGTFCVQEDGEGNCKGWYELP X X
GTHLYTITP Z, P
APLWDLVRWGAP X
ILGEGEGWNYNP Z, P X
FAIFLLLP Z
YSNVLPP X
SQWGWRGLSDP Z
GWGTFCVGEDGDGNCEEWYELP X
The X indicate the presence of specific core sequence in the strain or bloom sample. The Z indicate that the piricyclamide was detected with LC-MS. Posttranslational
modifications in addition to cyclization are indicated; G, geranyl, P, prenyl and SS, disulfide bridge.
*interrupted precursor gene.
doi:10.1371/journal.pone.0043002.t001
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failed to identify predicted cyanobactins from the cell extract of M.
aeruginosa NIES843. The pir gene cluster of M. aeruginosa NIES843
is 19 655 bp from 32581–52235. In the previous analysis the gene
cluster was analyzed forward from pirF gene [7] while two
precursor genes appear also upstream from pirF making the gene
cluster even longer than previously described. The bioinformatic
analysis of the pir gene cluster was complicated by many
interruptions and short hypothetical proteins as mentioned
previously [7]. The pirG in M. aeruginosa NIES843 has a frameshift
mutation at 508 position of MAE_00690. We identified two
insertion sequence elements in pirA gene of NIES843. IS1 has
a length of 4361 bp while IS2 has a length of 2367 bp and both
insertion sequences are flanked by terminal inverted repeats. IS1 is
flanked by a 404 bp duplicated region which contains 100 bp of
non-coding promoter and 300 bp of pirA. IS2 is flanked by a three
base pair direct repeat. The two insertion sequences encode
a transposase, which are found in over 30 IS elements in the
genome of NIES843. The entire pir gene cluster encodes three
precursor genes pirE1-pirE3. All three precursor peptides had
a very similar sequence except for the core peptide region which
encoded the putative cyanobactin product. The gene cluster
encodes all the essential genes for cyanobactin gene clusters but it
lacks the PatD heterocyclase and the PatG heterocycle oxidizing
domain from the C-terminal protease (Table S1).
Genetic rearrangements were also identified in precursor genes
from M. aeruginosa NIES102 and SYKE864 and one from the
natural sample, which would lead to silencing of the precursor
gene. A 95 bp MITE element was found in one of the pirE
precursor genes of SYKE 864. This insertion sequence element
was characterized by short terminal inverted repeats. We
identified frameshift mutations in precursor genes from NIES102
and a cloned pirE precursor from Lake Tuusulanja¨rvi.
The pir Gene Cluster from PCC7005
The pir gene cluster sequence in NIES843 was used to design
primers to amplify the entire pir gene cluster from PCC7005. The
core cyanobactin proteins of PCC7005 and NIES843 were almost
identical and very similar to anacyclamide, trichamide and
prenylagaramide biosynthetic enzymes (Table 2). The pir genes
are organized in the same order in PCC7005 and NIES843
(Figure 2). However, the size of pir gene cluster is ,9.4 kb in
PCC7005 and 19.6 kb inM. aeruginosa NIES843. In addition to the
three precursors PirE2-PirE4 the PCC7005 pir gene cluster
encodes two proteases PirA and PirG, putative geranyl transferase
PirF, PirB and PirC, which are essential, but the function is
unknown (Table 2). The pirE1 precursor gene was not found in the
pir gene cluster of PCC7005. The PCC7005 gene cluster was
cloned into E. coli and sequenced showing that we amplified and
cloned the pir cluster from the beginning of pirE3 (Figure 1)
onwards instead of entire cluster. LC-MS analysis showed that
only piricyclamide TFCDLATKQCYP (pirE4) was heterologously
expressed in E. coli. As the sequencing showed that the amplified
part encoded the essential genes and only precursor pirE4 with its
promoter, which is in the middle of the gene cluster. Subsequent
attempts allowed the amplification and cloning of the pir cluster
from the middle of pirE2 onwards. This part of the PCC7005 pir
gene cluster was cloned into E. coli and sequenced. Again in the
LC-MS analysis the same pirE4 encoded piricyclamide was
produced. The fragment cloned into E. coli had partial pirE2 and
no promoter for the pirE3. Attempts to extend the pir gene cluster
to include pirE1 were unsuccessful.
Diversity of Piricyclamides in a Natural Sample
The genetic diversity of piricyclamide precursor genes was
studied in a bloom sample from Lake Tuusulanja¨rvi. Bioinformatic
analysis of a 16S rRNA clone library constructed from the bloom
material suggested the sample to contain mainly Aphanizomenon
(97%) and Microcystis in lower frequencies (3%). The 122 pirE
precursor genes were sequenced from a library constructed from
the bloom material. The amino acid core sequences of the peptide
precursors varied extensively (Table 3). The metagenome showed
19 unique piricyclamide precursor genes. Two variants of the
precursor core sequence had a double cysteine pattern and
therefore the resulting structure would contain a sulphur bridge.
The length of hypothetical piricyclamides with disulfide bridges
was 10 and 22 amino acids. The remaining 17 piricyclamides had
variable core sequence from 7 to 17 amino acids (Table 3). Three
of the core sequences of the precursor metagenome were identical
to the ones in the strains studied while the remaining 16 putative
piricylamides were novel.
Phylogenetical Analyses
A phylogenetic analysis was made based on concatenated PirA
and PirG protease homologs from known cyanobactin gene
clusters. The maximum likelihood tree is well resolved and clearly
shows the divergence between microcyclamide and piricyclamide
cyanobactin gene clusters. Interestingly piricyclamide biosynthetic
machinery is most similar to trichamide, anacyclamide and
prenylagaramide gene clusters (Figure 2).
Discussion
Microcystis is a common cyanobacterium found in freshwater
lakes, ponds and reservoirs worldwide. It can form thick scums on
the surface of these water bodies during the summer and early
autumn. It is associated with human and livestock poisoning
through the production of microcystins which are potent inhibitors
of eukaryotic protein phosphatases. However, Microcystis strains
also produce a range of other natural products [23–24]. Here we
describe the discovery of piricyclamides from strains of the bloom-
forming genus Microcystis. These cyclic peptides belong to the ever-
expanding family of cyanobactins [4,7,10,12,15] and vary in
length, amino acid content and level of post-translational
modifications. The characteristic features of piricyclamides are
prenylation or geranylation, disulfide bridges, and the presence of
several different precursor genes in each strain. Surprisingly, the
strains exhibit incomplete post-translational modification in
geranyl and prenyl attachments and piricyclamides which were
not prenylated or geranylated were also found to an appreciable
level in some strains. This is in contrast to other cyanobactin
posttranslational modifications which seem to go to completion
such as heterocyclization [9–10]. Therefore each strain can,
through genetic and chemical variation, synthesize a range of
piricyclamides greater in number than might be expected from the
precursor gene sequence alone. In natural systems Microcystis
populations may synthesize a diverse selection of piricyclamide
precursor peptides, which is parlayed into a myriad of piricycla-
mides through partial posttranslational modification.
Disulfide Bridges
Just a small number of cyanobactins with sulphur bridges have
been described so far including ulithiacyclamides, which are
octapeptides as patellamides and produced by Prochloron [25–29].
In piricyclamides with disulfide bridges the length of the core
peptide is not restricted to eight amino acids as in ulithiacycla-
mides. We found piricyclamide precursors with a double cysteine
Piricyclamides from Microcystis Strains
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pattern and lengths varying from 12 to 22 amino acids.
Piricyclamides with the disulfide bridges resemble the plant
cyclotides [30]. In cyclotides the disulfide bridges stabilize the
structure in addition to the cyclic structure and make the structure
even more stabile [30].
Prenylation
Some of the piricyclamides were prenylated. The most similar
cyanobactins to piricyclamides are anacyclamides, planktocyclin
and prenylagaramides described in the strains of Anabaena P.
rubescens and P. agardhii respectively [7,12,31]. Interestingly, the
Figure 2. An unrooted maximum likelihood tree constructed from dataset of concatenated proteases (A and G) in cyanobactin
producers for which the biosynthetic genes have been described. Bootstrap values are from 1000 ML-bootstrap replicates. The branch
lengths are proportional to sequence change. Cyanobactins produced by Microcystis strains are highlighted in black.
doi:10.1371/journal.pone.0043002.g002
Table 2. The predicted proteins and their proposed functions in the piricyclamide gene cluster of Microcystis aeruginosa PCC7005.
Protein
Accession
Number Length (aa) Predicted function Blast result
Identity (%) Organism
PirE1 JX129192 48 Precursor 59 P. agardhii NIES596
PirE2 AFK79987 53 Precursor 56 M. aeruginosa NIES843
PirE3 AFK79988 51 Precursor 56 M. aeruginosa NIES843
PirF AFK79989 296 Prenylation 83 M. aeruginosa NIES843
ORF AFK79990 465 Hypothetical
ORF AFK79991 192 Hypothetical
ORF AFK79992 227 Hypothetical
PirA AFK79993 645 C-terminal protease 67 T. erythraeum IMS101
PirB AFK79994 69 Associated with cyanobactin biosynthesis 99 M. aeruginosa NIES843
PirC AFK79995 73 Associated with cyanobactin biosynthesis 81 M. aeruginosa PCC7806
PirE4 AFK79996 51 Precursor 98 M. aeruginosa NIES843
ORF AFK79997 271 Hypothetical
PirG AFK79998 689 N-terminal protease, macrocyclaze 96 M. aeruginosa NIES843
doi:10.1371/journal.pone.0043002.t002
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producers of anacyclamides, prenylagaramides, and piricyclamides
are all ecologically important cyanobacteria which can form toxic
cyanobacterial blooms in aquatic environments.
The undecapeptides kawaguchipeptin A and antibacterial
tryptophan prenylated variant kawaguchipeptin B, are found from
Microcystis aeruginosa NIES 88 [1,2]. Interestingly the structure of
kawaguchipeptin suggests the possibility of similar type of bio-
synthesis to piricyclamides and other cyanobactins [4]. However,
precursor genes could not be amplified from the genomic DNA of
M. aeruginosa NIES 88 in the screening of 74 strains of Microcystis
with the primers and PCR conditions we used for the precursor
amplification. It is possible that kawaguchipeptins are made by
a different type of cyanobactin pathway differing from both
microcyclamide and piricyclamide or perhaps is produced by
a different mechanism entirely.
The piricyclamide precursor peptides are similar to anacycla-
mide precursors in the strains of Anabaena and prenylagaramide
precursors in Planktothrix agardhii NIES596 [7]. In piricyclamides,
anacyclamides and prenylagaramides the amino acid content,
peptide length and also the level of post-translational prenylation
or geranylation varies. Prenylation was recently shown to be
achieved by LynF in lyngyabactin biosynthesis [11]. However,
LynF homologs are encoded in almost every cyanobactin gene
cluster yet only some of the gene clusters produce prenylated
cyanobactins. The PirF, the likely enzyme to geranylate the
piricyclamides, is similar to putative cyanobactin prenylating
enzymes and also to the homologues with no prenylation reported.
PirF is also very similar to AcyF encoded in anacyclamide gene
cluster in Anabaena sp. 90, which product anacyclamide was not
found to have isoprenoids linkages [12]. It is also intriguing why
only two of the four piricyclamides produced by M. aeruginosa
PCC7005 are geranylated and the two others are not. It may be
that the disulfide bridge prevents geranylation while the substrate
amino acid is absent in the other precursor peptide. The substrate
specificity for different cyclic precursors with free phenolic
hydroxyl group was shown to be broad to the putative cyanobactin
prenyltransferase in vitro [11].
Prenylation, geranylation and double prenylation was detected
from the Anabaena strains which produced anacyclamides [12] and
here similarly from the Microcystis which produced piricyclamides
(Table 1, Table S4). This is an analogous phenomenon in
eukaryotes where 3 different kinds of prenylations have been
detected from proteins including farnesylation, geranylgeranyla-
tion and double geranylgeranylation [32]. The functional signif-
icance of these different types of protein prenylations in
cyanobactins is unknown.
Piricyclamides in M. aeruginosa PCC7005
M. aeruginosa PCC7005 produced piricyclamides from four
precursor genes pirE1-pirE4 as in the cyanobactin screening we
found four precursor genes and piricyclamides corresponding
these genes from the cell extract by LC-MS. The gene cluster was
amplified and cloned into E. coli from pirE2 to pirG (Figure 1). In
the heterologous host piricyclamide with disulfide bridge from
pirE4 precursor was detected with LC-MS. The cloned fragment
had pirE3 and partial pirE2 lacking their promoter and therefore
only pirE4 was expressed. The location of the pirE1 precursor
remained unsolved but its products were found in the M. aeruginosa
PCC7005 cell extract. The pirE1 gene might be located further
distance away from the main cluster or in another part of the
genome.
Microcystis Cyanobactins
In addition to piricyclamides Microcystis strains also produce
another cyanobactin family microcyclamides [14]. The phyloge-
netic analysis of the cyanobactin biosynthetic genes shows the
divergence of microcyclamides and piricyclamides (Figure 2).
There are many differences in these two systems, which explain
the distant relationship of these cyanobactins even though
produced by the same organism. Piricyclamides show greater
diversity of amino acid content and number than microcycla-
mides. In the microcyclamides the structure is fixed to six amino
acids and those usually contain heterocyclized amino acids on
alternate positions with unmodified ones [3,15,16–18]. Instead of
the heterocycles piricyclamides can have isoprenoid attachments
and disulfide bridges. The absence of heterocycles is explained by
the lack of the heterocyclase enzyme in the piricyclamide
biosynthetic machinery. The difference of piricyclamides and
microcyclamides is seen also in the genetic level as the biosynthetic
genes of piricyclamides resemble more anacyclamide biosynthetic
genes in Anabaena [12] than microcyclamide genes of Microcystis
[15].
The structure of the peptide precursors is different in
microcyclamides and piricyclamides. As generally in cyanobactins
the microcyclamide core sequence diversity results from one
precursor peptide which has several core sequences [15,33]. In the
piricyclamides each core sequence is encoded in distinct precursor
gene. The different core sequences are derived from several
precursors. Hence, the diversity of cyanobactins can be created
from one or several precursors. The pathways with several
precursors appear to allow more length variation of the core
sequence as the single precursor pathway only encodes cyano-
bactins of the same number of amino acids. These two
cyanobactin families of the genus Microcystis are clearly different.
Table 3. Piricyclamide precursor core sequences found in the
bloom sample metagenome of 122 clones from Lake
Tuusulanja¨rvi 1987.
Number of
clones Core sequence Microcystis strain
38 APLWDLVRWGAP
21 DWGTFCVQEDGEGNCKEWYELP SYKE864
15 TGNKSGKVTP
9 QTIGYWKDP
7 MSGVDYYNP PCC7005
5 HQSLWAWNGSDP
4 GSGHPLYP
4 TVFDYTVP
4 HQWGWLVGGTDP
3 TRGCSFCPFP
2 FITWSWSIP
2 FTFPPFPPIGP
2 WVNRRIP
1 SWNIDWEYYGLSFPLSP
1 TAFDYTVP
1 FEFLGLRLP
1 TKYGYMFGTP
1 IYNGDGQPYFTLTAFYP
1 IWNQQKGRWEYIFATP
doi:10.1371/journal.pone.0043002.t003
Piricyclamides from Microcystis Strains
PLOS ONE | www.plosone.org 6 August 2012 | Volume 7 | Issue 8 | e43002
Cyanobactins are similar to other naturally occurring circular
proteins in bacteria, plants, fungi and animals. The cyclic nature of
the peptides provides a stabile structure which is protected against
proteases therefore cyclic peptides might have potential as drugs.
A common role of circular proteins appears to be in the defense
system of the producer organism [30]. The biological role of
cyanobactins remains so far unexplained.
Genetic Rearrangements
The M. aeruginosa NIES843 piricyclamide gene cluster is
fragmented and inactive due to insertion sequence mediated
rearrangements (Figure 1). Insertion sequences are common in the
genome of M. aeruginosa NIES843 [19] and PCC7806 [34] and the
plasticity of the genome has been suggested because of the high
number of mobile elements [19,34]. Insertion sequence mediated
inactivation of gene clusters in Microcystis is frequently occurring
event [19,34–35]. In addition to inactivation of pirA inM. aeruginosa
NIES843 the sequencing of the pirE precursors from NIES102
demonstrated that the precursors had been also target to genome
re-organizations, in this case through insertion of a non-autono-
mous MITE element. These shorter insertion elements are also
common in Microcystis [19] and have been associated with
inactivation of the microcystin synthetase gene cluster in Anabaena
[36]. This is even more likely to occur in other parts of the gene
cluster since the precursors are only 150 bp. Interruptions in the
cyanobactin genes may inactivate piricyclamide gene clusters
which might be the reason why some of the predicted
piricyclamides could not be detected. In addition the peptides
might have other post-translational modifications, which remained
to be identified.
Conclusion
The number of cyanobactins reported is rapidly growing and
the new genome sequences accelerate the discovery of new natural
products. Here we describe a new group of ribosomal natural
products in globally significant toxic cyanobacterium discovery
driven by analysis of inactive gene cluster. Piricyclamides are cyclic
peptides with a core of varying in length, amino acid content and
occasionally with disulfide bridge and isoprenoid attachments such
as prenyl and geranyl. We also demonstrated that the diversity of
piricyclamides occurring in nature is even higher than that
observed in laboratory strains. This shows the seemingly endless
variation on a common theme in natural products in nature even
in a single group of cyanobactins.
Experimental Procedures
Cyanobacterial Strains and Cultivation
The cyanobacterial strains used in the study were grown in 20–
40 ml of Z8 media [37] in continuous light of 5–12 mmol m22 s21
photon irradiance at 20–25uC for 7–42 days. The strains are from
the University of Helsinki culture collection, except the M.
aeruginosa PCC7005 was obtained from the PCC culture collection
and M. aeruginosa NIES843 from NIES culture collection. Stable
isotope labeling was used to determine the nitrogen and sulphur
content of the cyanobactins using LC-MS. In sulphur labeling
experiments the MgSO46 7 H2O of the Z8 media was replaced
with a stable isotope of MgSO4 (90 atom%
34S; Icon). In nitrogen
labeling experiments all the nitrogen sources of Z8 media was
replaced with a stable isotope of NaNO3 (98 atom %
15N;
IsotecTM).
Annotation of the pir Cluster in NIES843
The NIES843 cyanobactin gene cluster (AP009552) was re-
annotated manually using Artemis (Sanger Institute). We identified
three precursor genes pirE1-pirE3. The pirE3 precursor gene was
annotated in the genome as an unknown protein (MAE_00670)
and identified as a precursor gene in a previous study [7]. We
identified two more precursor genes, pirE1 and pirE2, by searching
for conserved N-terminal KKNxxPxxxxPVxR motif and C-
terminal FAGD motifs in all possible open reading frames
predicted using the glimmer program implemented in Artemis.
This motif is present in the N-terminal leader of cyanobactin
precursors as shown previously [12]. BLASTp searches were made
to characterize the functions of the putative proteins in the gene
cluster. The pirA and pirG genes had undergone genetic
rearrangements in M. aeruginosa NIES843 rendering the gene
cluster non-functional [7] and no cyanobactins could be identified
from this strain. We screened 74 Microcystis strains by PCR and
LC-MS in order to identify a functional cyanobactin cluster.
DNA Extraction, PCR Amplification and Sequencing
Microcystis cells were collected from 20 ml of liquid culture by
centrifugation at 7000 6 g for 7 min (Eppendorf Centrifuge
5804R, Eppendorf). DNA was extracted using the E.Z.N.A. plant
DNA mini kit (Omega Bio-Tek, Doraville, GA). The cells were
shaken with glass beads (Acid Washed, 425–600 and 710–1180
microns (1:1) Sigma-Aldrich) St. Louis, MO, USA) in a FastPrepTM
cell instrument with the speed of 5 m s21 for 30 s (FP120, Bio101,
Thermo Electron Corp. Qbiogene, Inc) in lysis buffer with
RNAase A (100 mg ml21) Oligonucleotide primers kgpF1 and
kgpR were designed to anneal to the conserved leader sequence
and C-terminal splicing site of the NIES843 precursor genes
(pirE1-pirE3). Genomic DNA of 74 Microcystis strains was screened
by PCR using the kgpF1 and kgpR primers. All the primers used
in the study are listed in the supporting information (Table S2).
The PCR was carried out as previously described [38] except the
primer concentration of 0.5 mM was used. The amplified pre-
cursor genes were cloned into the pCR 2.1-TOPO vector using
a TOPO TA cloning kit (Invitrogen) according to the manufac-
turer’s instructions. The resulting transformants were analyzed by
amplifying the insert with M13 primers and sequenced. In
sequencing BigDyeH Terminator Cycle Sequencing Ready Re-
action kit (version 3.1) (PE Applied Biosystems) was used and the
reactions were analyzed by ABI PRISM 310 Genetic Analyzer
capillary gel electrophoresis (PE Applied Biosystems). All the
sequences obtained in this study are deposited in GenBank
(JX129189-JX129192, JQ951924).
The pir Gene Cluster in PCC7005
The pir gene cluster was amplified from the genomic DNA of
PCC7005 with primer willaF1 and luckyR in three 50 ml reaction
mixtures containing 1 6 PCR Buffer for Super Taq Plus (HT
Biotechnology Ltd) 200 mmol of each nucleotide (Thermo Fischer
Scientific Inc. 0.75 mmol of each primer, 0.8 U of Super Taq Plus
proofreading polymerase (HT Biotechnology Ltd) and approxi-
mately 100 ng of template DNA. The cycling conditions were
94uC 3 min, followed by 35 cycles of 94uC for 30 s, 60uC for 30 s
and 68uC for 11 min and final extension of 20 min at 68uC. A gel
extraction of the PCR product was carried out as previously
described [12]. The 9290 bp fragment was cloned into the pCR
2.1-TOPO vector using a TOPO TA cloning kit (Invitrogen) with
insert-to-vector molar ratio of 3:1. The vector was used to
transform chemically competent Escherichia coli One Shot TOP10
cells according to manufacturer’s instructions. The resulting
plasmids were analyzed with restriction digest with BamHI
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(Promega) according to manufacturer’s instructions. Plasmids with
9290 bp insert were end sequenced to confirm it contained the
correct insert sequence. The entire insert was sequenced by primer
walking at Beijing Genomic Institute (Beijing, China). The
cyanobactin gene cluster of PCC7005 was manually (Acc. number)
annotated using Artemis (Sanger Institute). The predictions for the
starting sites of the proteins were checked. Two transformants
carrying plasmids with the 9290 bp insert, named pPIR7005, were
grown with shaking 120 rpm overnight at 28uC in 50 ml of LB
medium containing 50 mg ml21 of kanamycin sulphate salt
(Sigma-Aldrich) for the LC-MS analysis.
Cell Extractions for the Chemical Analysis
The E. coli pPIR7005 transformants and cells of Microcystis
cultivations were collected by centrifugation at 7000 6 g for
7 min. The cells were freeze dried with Supermodulyo (Edwards
High Vacuum International). The freeze dried cyanobacterial cells
yielded 4–10 mg dry weight and E. coli p7PIR7005 40 mg. The
freeze dried cells were extracted with 1 ml of methanol (HiperSolv
for HPLC, BDH Laboratory Supplies) and glass beads (Cell
disruption medium; 0.5 mm-diameter glass beads; Scientific
Industries Inc). The extracts were homogenized by shaking with
FastPrep cell disrupter instrument for 30 s with the speed of
6.5 m21 s21. This procedure was repeated three times and the cell
extracts were kept on ice between treatments. The resulting
mixture was centrifuged at 20 000 6 g for 10 min and the
supernatant was used in the chemical analysis.
Chemical Analyses
The extracts were analyzed with high-performance liquid
chromatography (HPLC) combined with a mass spectrometer
(MS) (Agilent 1100 series LC/MSD with Ion trap XCT Plus and
electrospray ion source). Peptides were separated with HPLC
using a Phenomenex C18 (alternatively C8) column (2.0 mm 6
150 mm; particle size, 5 mm). The mobile phase consisted of 0.1%
aqueous (Milli-Q Plus purified water) formic acid (50% solution in
water; Fluka, Sigma-Aldrich) as solvent A and 0.1% formic acid in
isopropyl alcohol (Sigma-Aldrich) as solvent B. The percentage of
solvent B was increased from 5% to 50% in 60 min. A flow rate of
0.15 ml min21 was used and the column was 40uC during
separation. Positive-ion mode of electrospray ionization was used.
The pressure of the nebulizer gas (N2) was 30 lb/in
2, the drying
gas flow rate was 8 l min21 and temperature was 350uC. The
capillary voltage was 5000 V and the capillary offset value was 300
V. A skimmer potential of 85 V and a trap drive value of 144 were
used. Spectra were recorded with a scan range of m/z 300 to m/z
2200. Piricyclamide candidates with an m/z above 2000 cannot be
easily detected with the mass spectrometer used. The identification
of piricyclamides was based on the ion mass predicted from the
precursor amino acid sequences and the product ion spectra (MSn,
n = 1 to 3). The number of sulphur or nitrogen atoms in the
peptides was verified with MS analysis of 34 S and 15N labelled
Microcystis cell extracts.
Disulfide Bridges
The presence of disulfide bridges was confirmed with
a carboxyamidomethylation method [39] in which the disulfide
bridge is first reduced (mass increase of 2 6 1 Da) and then
free thiols are alkylated with iodoacetamide (mass increase of 2
6 57 Da). Total mass increase of 116 Da demonstrates the
presence of a disulfide bridge in the molecule. One part of
water and one part of dichloromethane (Sigma-Aldrich) was
added to the raw methanol extract made from the cyanobacter-
ial cells as described above. The solution was mixed and the
centrifuged 10 000 6 g for 5 minutes. The upper layer was
removed to a 2 ml tube and evaporated and the resultant
residue was used in a derivatization reaction. Derivatization was
carried out as described [39] and the chemical analysis of the
derivatized peptide was performed with LC-MS as described
above. Matrix-assisted laser desorption/ionization time of flight
(MALDI-TOF) mass spectrometric analysis was made with an
Ultraflex TOF/TOF instrument (Bruker-Daltonik GmbH, Bre-
men, Germany). Angiotensin II (MH+ m/z 1046.542) was used
as an internal standard.
Phylogenetic Analyses
In order to explore the relationship between piricyclamide and
other cyanobactin gene clusters we constructed phylogenetic trees
based on a concatenated alignment of PirA (738 aa) and PirG (237
aa) homologs from cyanobactin gene clusters with known products
(Table S3). A manual alignment was constructed and ambiguous
and missing regions were excluded. The ‘‘oxidase’’ domain found
in PatG was omitted from the analysis as this domain is absent
from piricyclamide, anacyclamide, trichamide and prenylagar-
amide proteases. A total of 975 amino acids were subjected to
maximum-likelihood analysis using the PHYLIP package [40]. An
unrooted maximum-likelihood tree was constructed using ProtML
with the JTT-F model of amino acid substitution 10 random
sequence addition searches with global rearrangements. One
thousand likelihood bootstrap replicates were performed under
a JTT and uniform rate model with 5 random sequence additions
per replicate and global rearrangements.
Natural Sample
A freeze-dried natural sample from a bloom in Lake
Tuusulanja¨rvi on September 7th 1987 was analysed. The material
contained Aphanizomenon, Anabaena and Microcystis based on pre-
liminary microscopy in 1987. The freeze-dried material has been
stored at 220uC for 23 years before this analysis. DNA was
extracted and the precursor peptide genes were amplified from the
natural sample as described above. Clone libraries of 16S rRNA
gene and the pirE cyanobactin precursor gene were constructed
from the natural sample. The 16S rRNA gene was amplified using
the 359F and 781Ra/b primer pair [41]. BLASTn searches were
made with the resulting sequences. The pirE cyanobactin pre-
cursor genes were amplified as described above using the kgpF1
and kgpR primer pair. The resulting transformants were analyzed
and sequenced with M13 primers as described above.
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